Cited by 4

Snus and risk of gastroesophageal reflux. A population-based case-control study: the HUNT study

Lie, Tina Malene, Bomme, Maria, Hveem, Kristian, Hansen, Jane Møller, Ness-Jensen, Eivind·2017·Scandinavian Journal of Gastroenterology

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/00365521.2016.1245775

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Daily snus users compared to never users have reduced odds of gastroesophageal reflux symptoms (OR = 0.77; 95% CI: 0.64-0.93); former snus users and those using < 2 boxes per month have increased odds (OR = 1.20; 95% CI: 1.00-1.46 and OR = 1.41; 95% CI: 1.02-1.96, respectively).

    “reduced odds of gastroesophageal reflux symptoms (GERS) in daily snus users compared to never users (OR = 0.77; 95% CI: 0.64-0.93).However, former snus users and those using < 2 boxes of snus per month showed increased odds (OR = 1.20; 95% CI: 1.00-1.46and OR 1.41, 95% CI: 1.02-1.96,respectively) of GERS (Lie et al. 2017).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 29

  1. Idris AM, Ibrahim SO, Vasstrand EN, Johannessen AC, Lillehaug JR, Magnusson B, et al. The Swedish snus and the Sudanese toombak: are they different? Oral oncology. 1998 Nov;34(6):558-66. PubMed PMID: 9930371. Epub 1999/02/04. eng.
  2. Overland S, Skogen JC, Lissner L, Bjerkeset O, Tjora T, Stewart R. Snus use and cardiovascular risk factors in the general population: the HUNT3 study. Addiction (Abingdon, England). 2013 Nov;108(11):2019-28. PubMed PMID: 23909909. Epub 2013/08/06. eng.
  3. Piano MR, Benowitz NL, Fitzgerald GA, Corbridge S, Heath J, Hahn E, et al. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation. 2010 Oct 12;122(15):1520-44. PubMed PMID: 20837898. Epub 2010/09/15. eng.
  4. Biener L, McCausland K, Curry L, Cullen J. Prevalence of trial of snus products among adult smokers. American journal of public health. 2011 Oct;101(10):1874-6. PubMed PMID: 21330582. Pubmed Central PMCID: Pmc3139789. Epub 2011/02/19. eng.
  5. Norberg M, Malmberg G, Ng N, Brostrom G. Who is using snus? -Time trends, socioeconomic and geographic characteristics of snus users in the ageing Swedish population. BMC public health. 2011;11:929. PubMed PMID: 22169061. Pubmed Central PMCID: Pmc3267833. Epub 2011/12/16. eng.
  6. Benowitz NL, Porchet H, Sheiner L, Jacob P, 3rd. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clinical pharmacology and therapeutics. 1988 Jul;44(1):23-8. PubMed PMID: 3391001. Epub 1988/07/01. eng.
  7. Digard H, Errington G, Richter A, McAdam K. Patterns and behaviors of snus consumption in Sweden. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2009 Oct;11(10):1175-81. PubMed PMID: 19687306. Pubmed Central PMCID: Pmc2746836. Epub 2009/08/19. eng.
  8. Bolinder GM, Ahlborg BO, Lindell JH. Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey. Journal of internal medicine. 1992 Oct;232(4):327-34. PubMed PMID: 1402636. Epub 1992/10/01. eng.
  9. Stepanov I, Jensen J, Hatsukami D, Hecht SS. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2008 Dec;10(12):1773-82. PubMed PMID: 19023828. Pubmed Central PMCID: Pmc2892835. Epub 2008/11/22. eng.
  10. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013 Mar;108(3):308-28; quiz 29. PubMed PMID: 23419381.
  11. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. The American journal of gastroenterology. 2006 Aug;101(8):1900-20; quiz 43. PubMed PMID: 16928254. Epub 2006/08/25. eng.
  12. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro- oesophageal reflux disease: a systematic review. Gut. 2014 Jun;63(6):871-80. PubMed PMID: 23853213. Pubmed Central PMCID: 4046948.
  13. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990 Jan 27;335(8683):205-8. PubMed PMID: 1967675. Epub 1990/01/27. eng.
  14. Ronkainen J, Aro P, Storskrubb T, Lind T, Bolling-Sternevald E, Junghard O, et al. Gastro- oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Alimentary pharmacology & therapeutics. 2006 Jun 15;23(12):1725-33. PubMed PMID: 16817916. Epub 2006/07/05. eng.
  15. Wahlqvist P, Reilly MC, Barkun A. Systematic review: the impact of gastro-oesophageal reflux disease on work productivity. Alimentary pharmacology & therapeutics. 2006 Jul 15;24(2):259-72. PubMed PMID: 16842452. Epub 2006/07/18. eng.
  16. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. The New England journal of medicine. 1999 Mar 18;340(11):825-31. PubMed PMID: 10080844. Epub 1999/03/18. eng.
  17. Hallan A, Bomme M, Hveem K, Moller-Hansen J, Ness-Jensen E. Risk Factors on the Development of New-Onset Gastroesophageal Reflux Symptoms. A Population-Based Prospective Cohort Study: The HUNT Study. Am J Gastroenterol. 2015 Mar;110(3):393-400. PubMed PMID: 25665934.
  18. Kadakia SC, Kikendall JW, Maydonovitch C, Johnson LF. Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring. The American journal of gastroenterology. 1995 Oct;90(10):1785-90. PubMed PMID: 7572895. Epub 1995/10/01. eng.
  19. Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol. 2015 May 6. PubMed PMID: 25956834.
  20. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut. 2004 Dec;53(12):1730-5. PubMed PMID: 15542505. Pubmed Central PMCID: 1774312. Epub 2004/11/16. eng.
  21. Aro P, Ronkainen J, Storskrubb T, Vieth M, Engstrand L, Johansson SE, et al. Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study). European journal of epidemiology. 2010 Oct;25(10):741-50. PubMed PMID: 20668918. Epub 2010/07/30. eng.
  22. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003 Jul 2;290(1):66-72. PubMed PMID: 12837713. Epub 2003/07/03. eng.
  23. Ness-Jensen E, Lindam A, Lagergren J, Hveem K. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut. 2012 Oct;61(10):1390-7. PubMed PMID: 22190483. Epub 2011/12/23. eng.
  24. Langhammer A, Krokstad S, Romundstad P, Heggland J, Holmen J. The HUNT study: participation is associated with survival and depends on socioeconomic status, diseases and symptoms. BMC medical research methodology. 2012;12:143. PubMed PMID: 22978749. Pubmed Central PMCID: Pmc3512497. Epub 2012/09/18. eng.
  25. Winding TN, Andersen JH, Labriola M, Nohr EA. Initial non-participation and loss to follow-up in a Danish youth cohort: implications for relative risk estimates. Journal of epidemiology and community health. 2014 Feb;68(2):137-44. PubMed PMID: 24072742. Epub 2013/09/28. eng.
  26. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005 May;54(5):710-7. PubMed PMID: 15831922. Pubmed Central PMCID: 1774487. Epub 2005/04/16. eng.
  27. Post A, Gilljam H, Rosendahl I, Meurling L, Bremberg S, Galanti MR. Validity of self reports in a cohort of Swedish adolescent smokers and smokeless tobacco (snus) users. Tobacco control. 2005 Apr;14(2):114-7. PubMed PMID: 15791021. Pubmed Central PMCID: Pmc1747998. Epub 2005/03/26. eng.
  28. Hellqvist L, Rolandsson M, Hugoson A, Lingstrom P, Birkhed D. Dental caries and associated factors in a group of Swedish snus users. Swed Dent J. 2015;39(1):47-54. PubMed PMID: 26529841.
  29. Rutqvist LE, Curvall M, Hassler T, Ringberger T, Wahlberg I. Swedish snus and the GothiaTek(R) standard. Harm reduction journal. 2011;8:11. PubMed PMID: 21575206. Pubmed Central PMCID: Pmc3119032. Epub 2011/05/18. eng. Missing, no. (%) 74 (19.9) 954 (33.0) 2,203 (29.3) Smoking status Never smokers, no. (%) 977 (32.6) 12,351 (46.4) 24,521 (41.8) Previous smokers, no. (%) 1,176 (39.3) 7,666 (28.8) 18,241 (31.1)

Authors
Lie, T. M., Bomme, M., Hveem, K., Hansen, J. M., & Ness-Jensen, E.
Venue
Scandinavian Journal of Gastroenterology
Published
2016-10-31
Volume
52
Issue
2
Pages
193-198
ISSN
  • 0036-5521
  • 1502-7708
Cited by
4
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review